HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haiyan Yang Selected Research

Ascites

3/2022SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation.
7/2021Trans-jugular intrahepatic portosystemic shunt in patients with hepatic cellular carcinoma: A preliminary study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haiyan Yang Research Topics

Disease

74Neoplasms (Cancer)
04/2024 - 03/2003
19Infections
03/2024 - 08/2011
17Lung Neoplasms (Lung Cancer)
03/2024 - 11/2009
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 01/2013
13Neoplasm Metastasis (Metastasis)
12/2021 - 01/2004
12Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 01/2015
11Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
02/2024 - 11/2016
11Breast Neoplasms (Breast Cancer)
12/2022 - 01/2015
10Disease Progression
12/2023 - 01/2020
10COVID-19
01/2023 - 01/2020
9Lymphoma (Lymphomas)
11/2023 - 01/2020
9Carcinogenesis
12/2022 - 03/2002
8Adenocarcinoma
01/2024 - 04/2011
7Inflammation (Inflammations)
02/2024 - 01/2014
6Stroke (Strokes)
02/2024 - 01/2022
5Ischemic Stroke
02/2024 - 06/2021
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2023 - 01/2020
5Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 02/2012
5B-Cell Lymphoma (Lymphoma, B Cell)
02/2023 - 01/2020
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022 - 11/2012
5Adenocarcinoma of Lung
03/2022 - 12/2017
5Hemorrhage
01/2022 - 07/2007
4Carcinoma (Carcinomatosis)
04/2024 - 04/2011
4Insulin Resistance
03/2024 - 01/2021
4Brain Ischemia (Cerebral Ischemia)
02/2024 - 01/2022
4Infarction (Infarctions)
02/2024 - 06/2021
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2023 - 01/2017
4Epilepsy (Aura)
11/2023 - 12/2019
4Endometriosis
11/2023 - 01/2022
4Type 2 Diabetes Mellitus (MODY)
11/2023 - 01/2019
4Hodgkin Disease (Hodgkin's Disease)
01/2023 - 01/2020
4Stomach Neoplasms (Stomach Cancer)
03/2022 - 04/2014
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 08/2014
4Neutropenia
01/2022 - 08/2016
4Hepatocellular Carcinoma (Hepatoma)
07/2021 - 09/2014
4Hypoxia (Hypoxemia)
01/2021 - 08/2018
4Brain Neoplasms (Brain Tumor)
01/2020 - 01/2013
3Colitis
02/2024 - 01/2023
3Reperfusion Injury
02/2024 - 01/2022
3Brain Injuries (Brain Injury)
02/2024 - 01/2022
3Neuroinflammatory Diseases
02/2024 - 01/2022
3Hyperuricemia
01/2024 - 10/2018
3Pneumonia (Pneumonitis)
01/2024 - 08/2011
3Obesity
11/2023 - 11/2016
3Glioblastoma (Glioblastoma Multiforme)
05/2023 - 01/2015
3Cognitive Dysfunction
05/2023 - 01/2015
3Multiple Myeloma
01/2023 - 01/2019
3Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease)
01/2023 - 01/2014
3Adrenocortical Carcinoma
06/2021 - 11/2019

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2004
13Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2015
9Therapeutic UsesIBA
10/2023 - 12/2004
9Messenger RNA (mRNA)IBA
01/2023 - 01/2004
8VaccinesIBA
03/2024 - 01/2020
7Long Noncoding RNAIBA
04/2022 - 01/2015
6Tyrosine Kinase InhibitorsIBA
01/2024 - 01/2013
6zanubrutinibIBA
09/2023 - 01/2020
6Rituximab (Mabthera)FDA Link
12/2022 - 11/2012
5Cisplatin (Platino)FDA LinkGeneric
04/2024 - 01/2016
5Uric Acid (Urate)IBA
02/2024 - 10/2018
5Phosphotransferases (Kinase)IBA
01/2024 - 01/2018
5CytokinesIBA
12/2023 - 01/2014
5Immune Checkpoint InhibitorsIBA
10/2023 - 01/2021
4RNA (Ribonucleic Acid)IBA
04/2024 - 08/2020
4CadmiumIBA
03/2024 - 07/2019
4LipidsIBA
03/2024 - 11/2016
4Hormones (Hormone)IBA
02/2024 - 06/2015
4Glucose (Dextrose)FDA LinkGeneric
12/2023 - 11/2016
4Antiviral Agents (Antivirals)IBA
12/2023 - 01/2021
4Luteinizing Hormone (Lutropin)FDA LinkGeneric
10/2023 - 06/2015
4tislelizumabIBA
01/2023 - 01/2020
4Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 01/2019
4CrizotinibIBA
03/2022 - 01/2020
4Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 01/2020
4ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2013
4CarcinogensIBA
03/2020 - 03/2010
4AgarIBA
12/2017 - 09/2016
3Neuroprotective AgentsIBA
02/2024 - 06/2021
3AntioxidantsIBA
02/2024 - 01/2022
3Triglycerides (Triacylglycerol)IBA
12/2023 - 01/2021
3Blood Glucose (Blood Sugar)IBA
11/2023 - 11/2016
3relmacabtagene autoleucelIBA
01/2023 - 01/2021
3AntibodiesIBA
03/2022 - 11/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2015
3Estradiol (Delestrogen)FDA LinkGeneric
01/2022 - 01/2021
3Retinaldehyde (Retinal)IBA
01/2022 - 11/2021
3Bevacizumab (Avastin)FDA Link
01/2022 - 01/2020
3Small Interfering RNA (siRNA)IBA
12/2021 - 10/2018
3Mitogen-Activated Protein KinasesIBA
11/2021 - 08/2014
3N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
01/2021 - 01/2017
3Follicle Stimulating Hormone (Follitropin)FDA Link
01/2021 - 06/2015
3MicroRNAs (MicroRNA)IBA
08/2020 - 01/2015
3Oxidoreductases (Dehydrogenase)IBA
01/2020 - 07/2017
3Benzo(a)pyreneIBA
12/2019 - 06/2018
3Histone Deacetylase InhibitorsIBA
10/2018 - 01/2015

Therapy/Procedure

46Therapeutics
04/2024 - 12/2004
17Drug Therapy (Chemotherapy)
01/2024 - 01/2013
9Immunotherapy
04/2024 - 01/2021
4Radiotherapy
01/2023 - 09/2015
3Extracorporeal Shockwave Therapy
03/2021 - 01/2020